Answers are grounded in this paper and cite their sources.
Scientists continue to investigate the use of Kigelia Africana plant parts for the management of diabetes. However, there is still little published information discussing active antidiabetic principles, especially in the fruit. Further, there is limited information discussing the mechanism by which the plant extract provides its antidiabetic activity. While studies have showed that the plant stem bark’s extract has a large therapeutic index, there is no published information discussing the mutagenic properties of the plant.
No takes yet. Share an insight, caveat, or question.
Akapelwa et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: